Delcath Systems Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics

What is ROE for Delcath Systems Inc in the second quarter 2026?
Delcath Systems Inc achieved a return on average equity (ROE) of 0.46 % in its second quarter 2026, this is above DCTH's average return on equity of -366.99%.
Delcath Systems Inc shareholder's equity over the 12 months ending in its second quarter 2026 are valued at $115 million

ROE fell compared to the first quarter 2026, despite the net income growth of % from the first quarter 2026.

Within the Medical Equipment & Supplies industry 62 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the first quarter 2026 from 2153 to 2278.

What is ROE?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Equity ROE▼

None ▼

Return on Equity ROE▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Equity	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Equity Change	15.39 %	40.48 %	61.78 %	1239.95 %	-
Y / Y Net Income Change	-1.08 %	-	-	-55.47 %	-
Net Income (TTM) in Millions	1	1	3	1	2
Return On Equity (TTM)	0.46 %	0.51 %	2.63 %	1.3 %	3.4 %
DCTH's Total Ranking	# 2278	# 2153	# 1724	# 1937	#
Equity (TTM) in Millions	121	113	111	115	105
Seq. Equity Change	7.48 %	1.34 %	-3.16 %	9.39 %	30.86 %
Seq. Net Income Change	-	-	-	-69.23 %	152.29 %

Back to DCTH Management Effectiveness >> DCTH's 5 Years Annual ROE >> Compare DCTH ROE to its Competitors

Return On Equity Company Ranking
Within:	No.
Industry	# 63
Sector	# 189
Overall	# 2278

Return On Equity Statistics
High	Average	Low
3.4 %	-366.99 %	-3369.54 %
(Jun 30 2025)		(Sep 30 2023)

DCTH Annual Return On Equity	(Dec 31 2025) 2025	(Dec 31 2024) 2024	(Dec 31 2023) 2023	(Dec 31 2022) 2022	(Dec 31 2021) 2021
Total Equity in Millions	111	69	16	-6	12
Y / Y Equity Change	61.78 %	335.74 %	-	-	-45.86 %
Net Income in Millions	3	-26	-48	-37	-26
Y / Y Net Income Change	-	-	-	-	-
Return On Equity	2.43 %	-38.38 %	-302.2 %	-	-214.6 %

Back to DCTH Management Effectiveness >> DCTH's 5 Years Annual ROE >> Compare DCTH ROE to its Competitors

Annual Roe Comment

In 2025 ROE improved to 2.43 % compared to the previous year, due to net income growth.

More Return On Equity Ratios
Medical Equipment & Supplies Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
DCTH's' Return on Equity at Yahoo Finance
DCTH's Roe Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for DCTH's Competitors
Subscribers only: Roe for Delcath Systems Inc 's Suppliers
Subscribers only: Return On Equity for DCTH's Customers

Companies with similar Return On Equity at Jun 30 2026, within Healthcare Sector	ROE
Biomarin Pharmaceutical Inc	1.18 %
Staar Surgical Co	1.08 %
Champions Oncology Inc	0.94 %
Delcath Systems Inc	0.46 %
Talkspace Inc	0.17 %
Denali Therapeutics Inc	0.11 %

Date modified: 2026-09-08T17:23:35+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.